In 2023, the mortality rate for chronic liver diseases and cirrhosis in the US for men stood at approximately 23.6 units per hundred thousand men. From 2024 to 2028, there is a forecasted rising trend in mortality rates, increasing from 24.2 to 26.8 units per hundred thousand men. Year-on-year, the mortality rate is expected to rise consistently, with percentage increases each year observed around 3-4%. The compound annual growth rate (CAGR) over the five years is projected to be around 2.8%.
Future trends to watch for include advancements in liver disease treatments and public health initiatives aimed at reducing risk factors such as alcohol consumption and obesity. Monitoring legislative efforts and healthcare policies will also be critical in understanding potential shifts in these projections.
